lobbying_activities: 1446954

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1446954	d2a6ee41-4e40-4b98-97aa-13c8a2c74e55	Q3	CONSUMER HEALTHCARE PRODUCTS ASSOCIATION	29403	CONSUMER HEALTHCARE PRODUCTS ASSOCIATION	2013	third_quarter	FOO	Dietary SupplementsReintroduction of S. 3431 - Designer Anabolic Steroid Control Act (DASCA, 112th Congress). Food and Drug Administration (FDA) regulation of anabolic steroids; all sections. Reintroduction of H.R. 1364 - Free Speech About Science Act of 2011 (112th Congress). Food and Drug Administration (FDA) regulation of dietary supplements labeling; all sections. Food and Drug Administration (FDA) draft "Guidance for Industry: New Dietary Ingredient Notifications and Related Issues."	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE		280000	0	0	2013-10-17T13:54:35.443000-04:00